Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Novak

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Ebiomedicine|December 15, 2023
Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trialNicholas C Cullen, Petr Novak, Duygu Tosun, et al.
The Plant Journal : for Cell and Molecular Biology|March 23, 2013
Diploidization and genome size change in allopolyploids is associated with differential dynamics of low- and high-copy sequencesSimon Renny-Byfield, Ales Kovarik, Laura J Kelly, et al.
Protein Science : a Publication of the Protein Society|May 30, 2006
Structure and dynamics of dark-state bovine rhodopsin revealed by chemical cross-linking and high-resolution mass spectrometryRichard B Jacobsen, Kenneth L Sale, Marites J Ayson, et al.
Clinical Proteomics|May 11, 2023
The rapid detection of procalcitonin in septic serum using immunoaffinity MALDI chipsJosef Dvorak, Jana Novakova, Lucie Kraftova, et al.
Acta Neuropathologica Communications|April 4, 2024
Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation modelsNeha Basheer, Luc Buee, Jean-Pierre Brion, et al.
Journal of Natural Products|June 1, 2010
Characterization of pseudacyclins A-E, a suite of cyclic peptides produced by Pseudallescheria boydiiKaterina Pavlaskova, Jan Nedved, Marek Kuzma, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterationsJames C Garbe, Lukas Vrba, Klara Sputova, et al.
Alzheimer'S Research & Therapy|November 23, 2024
Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217Branislav Kovacech, Nicholas C Cullen, Petr Novak, et al.
The Journal of Biological Chemistry|April 29, 2026
Calcium-loaded acylated segment controls membrane penetration capacity of repeats-in-toxin cytolysinsJiri Masin, Adriana Osickova, Zuzana Kalaninova, et al.
Digestive Diseases and Sciences|September 20, 2013
Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver diseaseJohn D Clarke, Petr Novak, April D Lake, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Ebiomedicine|December 15, 2023
Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trialNicholas C Cullen, Petr Novak, Duygu Tosun, et al.
The Plant Journal : for Cell and Molecular Biology|March 23, 2013
Diploidization and genome size change in allopolyploids is associated with differential dynamics of low- and high-copy sequencesSimon Renny-Byfield, Ales Kovarik, Laura J Kelly, et al.
Protein Science : a Publication of the Protein Society|May 30, 2006
Structure and dynamics of dark-state bovine rhodopsin revealed by chemical cross-linking and high-resolution mass spectrometryRichard B Jacobsen, Kenneth L Sale, Marites J Ayson, et al.
Clinical Proteomics|May 11, 2023
The rapid detection of procalcitonin in septic serum using immunoaffinity MALDI chipsJosef Dvorak, Jana Novakova, Lucie Kraftova, et al.
Acta Neuropathologica Communications|April 4, 2024
Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation modelsNeha Basheer, Luc Buee, Jean-Pierre Brion, et al.
Journal of Natural Products|June 1, 2010
Characterization of pseudacyclins A-E, a suite of cyclic peptides produced by Pseudallescheria boydiiKaterina Pavlaskova, Jan Nedved, Marek Kuzma, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterationsJames C Garbe, Lukas Vrba, Klara Sputova, et al.
Alzheimer'S Research & Therapy|November 23, 2024
Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217Branislav Kovacech, Nicholas C Cullen, Petr Novak, et al.
The Journal of Biological Chemistry|April 29, 2026
Calcium-loaded acylated segment controls membrane penetration capacity of repeats-in-toxin cytolysinsJiri Masin, Adriana Osickova, Zuzana Kalaninova, et al.
Digestive Diseases and Sciences|September 20, 2013
Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver diseaseJohn D Clarke, Petr Novak, April D Lake, et al.
Pageof 13